Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Halfmann

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
The Lancet. Infectious Diseases|February 11, 2023
Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolateRyuta Uraki, Mutsumi Ito, Maki Kiso, et al.
Cell Reports|June 7, 2022
Parsing the role of NSP1 in SARS-CoV-2 infectionTal Fisher, Avi Gluck, Krishna Narayanan, et al.
Immunohorizons|August 16, 2021
Specific COVID-19 Symptoms Correlate with High Antibody Levels against SARS-CoV-2Maya F Amjadi, Sarah E O'Connell, Tammy Armbrust, et al.
Medrxiv : the Preprint Server for Health Sciences|January 14, 2021
Fever, Diarrhea, and Severe Disease Correlate with High Persistent Antibody Levels against SARS-CoV-2Maya F Amjadi, Sarah E O'Connell, Tammy Armbrust, et al.
Med (New York, N.Y.)|May 18, 2022
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2Tamarand L Darling, Baoling Ying, Bradley Whitener, et al.
Plos Pathogens|September 30, 2022
Shedding of infectious SARS-CoV-2 despite vaccinationKasen K Riemersma, Luis A Haddock, Nancy A Wilson, et al.
Mbio|November 16, 2021
Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on SpikeSiriruk Changrob, Yanbin Fu, Jenna J Guthmiller, et al.
Nature|November 2, 2022
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodentsRyuta Uraki, Peter J Halfmann, Shun Iida, et al.
Virus Evolution|September 11, 2023
Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individualPeter J Halfmann, Nicholas R Minor, Luis A Haddock Iii, et al.
Immunity|April 14, 2021
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virusBronwyn M Gunn, Richard Lu, Matthew D Slein, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
The Lancet. Infectious Diseases|February 11, 2023
Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolateRyuta Uraki, Mutsumi Ito, Maki Kiso, et al.
Cell Reports|June 7, 2022
Parsing the role of NSP1 in SARS-CoV-2 infectionTal Fisher, Avi Gluck, Krishna Narayanan, et al.
Immunohorizons|August 16, 2021
Specific COVID-19 Symptoms Correlate with High Antibody Levels against SARS-CoV-2Maya F Amjadi, Sarah E O'Connell, Tammy Armbrust, et al.
Medrxiv : the Preprint Server for Health Sciences|January 14, 2021
Fever, Diarrhea, and Severe Disease Correlate with High Persistent Antibody Levels against SARS-CoV-2Maya F Amjadi, Sarah E O'Connell, Tammy Armbrust, et al.
Med (New York, N.Y.)|May 18, 2022
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2Tamarand L Darling, Baoling Ying, Bradley Whitener, et al.
Plos Pathogens|September 30, 2022
Shedding of infectious SARS-CoV-2 despite vaccinationKasen K Riemersma, Luis A Haddock, Nancy A Wilson, et al.
Mbio|November 16, 2021
Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on SpikeSiriruk Changrob, Yanbin Fu, Jenna J Guthmiller, et al.
Nature|November 2, 2022
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodentsRyuta Uraki, Peter J Halfmann, Shun Iida, et al.
Virus Evolution|September 11, 2023
Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individualPeter J Halfmann, Nicholas R Minor, Luis A Haddock Iii, et al.
Immunity|April 14, 2021
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virusBronwyn M Gunn, Richard Lu, Matthew D Slein, et al.
Pageof 12